Rockwell MedicalRMTI +0.02%30 Market Cap is $25.86 Mil as of Jun. 29, 2026. GuruFocus rates RMTI with a GF Score™ of 30/100 and a GF Value™ of $0.87 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Rockwell Medical ranks worse than 75.69% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Rockwell Medical's share price for the quarter that ended in Mar. 2026 was $0.8932. Rockwell Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 39.47 Mil. Therefore, Rockwell Medical's market cap for the quarter that ended in Mar. 2026 was $35.25 Mil.
Rockwell Medical's quarterly market cap
declined
from Sep. 2025 ($47.29 Mil) to Dec. 2025 ($32.84 Mil) but then
increased
from Dec. 2025 ($32.84 Mil) to Mar. 2026 ($35.25 Mil).
Rockwell Medical's annual market cap
increased
from Dec. 2023 ($55.06 Mil) to Dec. 2024 ($69.48 Mil) but then
declined
from Dec. 2024 ($69.48 Mil) to Dec. 2025 ($32.84 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Rockwell Medical's Enterprise Value for Today is $16.36 Mil.
Rockwell Medical (NAS:RMTI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Rockwell Medical Market Cap Related Terms
Rockwell Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Rockwell Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rockwell Medical Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Rockwell Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Rockwell Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rockwell Medical (RMTI) has a Market Cap of $25.86 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rockwell Medical and its competitors. According to the industry distribution chart, Rockwell Medical ranks #772 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 75.7%.
Is Rockwell Medical's Market Cap too high?
Rockwell Medical's current Market Cap is $25.86 Mil. The Drug Manufacturers industry median Market Cap is 206.61. Rockwell Medical's value of $25.86 Mil is 87.5% below this industry median. Based on the distribution chart, Rockwell Medical ranks #772 out of 1020 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Rockwell Medical has a GF Score™ of 30/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Market Cap compare to CPHI and TXMD?
According to the Drug Manufacturers industry distribution chart, Rockwell Medical ranks #772 out of 1020 companies for Market Cap. This places Rockwell Medical in the lower half of its industry. The industry median Market Cap is 206.61. Rockwell Medical's value of $25.86 Mil is 87.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.61, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rockwell Medical's current Market Cap of $25.86 Mil is 87.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rockwell Medical and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rockwell Medical's current Market Cap is $25.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (RMTI) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.87, compared to a current price of $0.66 — trading 24.7% below its estimated fair value. The current Market Cap is $25.86 Mil and 87.5% below the Drug Manufacturers industry median of 206.61. Rockwell Medical's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Rockwell Medical (RMTI), the current Market Cap is $25.86 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rockwell Medical (RMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Rockwell Medical stock appears to be undervalued.
The current stock price of $0.66 is trading 24.7% below its estimated GF Value™ of $0.87.
GuruFocus considers Rockwell Medical to be Modestly Undervalued.
Key valuation signals for RMTI:
Market Cap: $25.86 Mil
GF Value™: $0.87 vs. price of $0.66 (24.7% below fair value)
Industry Position: 87.5% below the Drug Manufacturers median (#772 of 1020)
No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
30GF Score
Get the complete analysis for RMTI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RMTI has been successfully added to your 
